SEATTLE — There's new hope for people in the early stages of Alzheimer's disease. A new medication called donanemab appears ...

The causes of Alzheimer’s disease have long puzzled researchers, especially when most older adults show signs of the illness ...

JOHNSON CITY, TENN (WCYB) — Despite a rainy start to the morning, participants laced up their shoes and gathered in Johnson ...

The Trump administration has been conducting a restructuring of the US Department of Health and Human Services as well as a ...

The outlook on the prevention, diagnosis and treatment of Alzheimer’s disease is brighter than ever. Backed by decades of ...

A new study found that a gene recently recognized as a biomarker for Alzheimer's disease is actually a cause of it, due to its previously unknown secondary function.

A new study found that a gene recently recognized as a biomarker for Alzheimer's disease is actually a cause of it, due to its previously unknown secondary function that triggers a pathway that ...

UW has begun treating patients with donanemab, a new Alzheimer’s medication that may slow cognitive decline in people with early-stage disease.

When parents imagine their child's future, they picture graduations, careers, and perhaps families of their own. For Bryan ...

Researchers have discovered that a gene previously seen as a biomarker for Alzheimer’s disease, PHGDH, actually plays a ...

From new cancer therapies to innovative military health care and technology, Harvard's cutting-edge projects are in jeopardy ...